INSIGHTS ON DRUG DEVELOPMENT
-
![The Emulate Organ-Chip Portfolio]( "The Organ-Chip Portfolio")
The Organ-Chip PortfolioWatch to learn about an organ-chip that has been designed to reduce drug absorption while improving biological modeling to provide researchers with enhanced accuracy in forecasting human drug response.
-
![injectables safety eurofins]( "Safety Of Injectables: Ensuring Purity Via Endotoxin Testing")
Safety Of Injectables: Ensuring Purity Via Endotoxin TestingAdvance pharmaceutical quality and sustainability by adopting recombinant factor C testing for reliable, animal-free endotoxin detection.
-
![Optimizing Your mAb Capture And Polishing With The Latest Resins And Tips]( "Optimize Your mAb Capture And Polishing With The Latest Resins And Tips")
Optimize Your mAb Capture And Polishing With The Latest Resins And TipsDiscover the latest innovations in monoclonal antibody purification and explore resin selection strategies to optimize product quality and improve process efficiency.
-
![GettyImages-2223536069 protein]( "Enable Low Volume Delivery Of Proteins In Aqueous Solutions")
Enable Low Volume Delivery Of Proteins In Aqueous SolutionsAchieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.
-
ADC Tech Talks Contract Manufacturing12/9/2024
Experts share strategies to accelerate ADC development, including optimizing supply chains, seamless scale-up to GMP manufacturing, and leveraging process analytical technology.
-
Understanding Adeno-Associated Virus Vector Impurities11/13/2025
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.
-
Injection Site Reaction Screening Methodology6/6/2025
Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.
-
Accelerating Small Molecule Development With Cutting-Edge Technology3/12/2026
Discover Asymchem Sandwich, our advanced small molecule facility at Discovery Park, Kent.
-
How Adept Formulation Helps Overcome Manufacturability Challenges6/17/2026
Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.
DRUG DEVELOPMENT SOLUTIONS
-
![mPredict™ Co-Crystal Prediction Service]( "Co-Crystal Prediction Service")
AI-driven co-crystal prediction accelerates solubility optimization by identifying ideal co-formers in days without needing the drug substance. Learn how to save time, reduce costs, and boost formulation success.
-
![SCIEX M5 MicroLC System]( "SCIEX M5 MicroLC System")
See More with Microflow LC-MS
The M5 MicroLC system is the perfect balance of sensitivity and robustness—more sensitive than traditional analytical flow LC, and more flexible and more robust than nanoflow LC — giving you the potential to optimize your critical workflows, today and into the future.
-
![Bench-Top Syringe Cartridge Closing System]( "Pharmaceutical Bench-Top Filling & Closing Machines: GENiSYS® Lab")
AST’s line of table-top machines, GENiSYS® Lab, are ideal systems for drug product development and cGMP production applications. Each system is designed to automate the critical aseptic operations for vial, syringe and cartridge processing to reduce contamination risk and product variability. These table-top systems are engineered to have complete compatibility with cleanroom environments, including Laminar Air Flow Hoods, Bio-Safety Cabinets and aseptic isolators.
-
![GettyImages-1790844511-assay-laboratory-machine-plate]( "Patent-Pending Bioprocess Technology For Scalable Organoid Production")
The 3D Ready™ Organoid Expansion Service provides researchers with large numbers of high quality, low-variability organoids in a convenient assay-ready format.
-
![GettyImages-1171312168-lab-development-research]( "A CDMO With Oral Solid Dose And Sterile Injectable Expertise")
Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.
